Laurus Labs Limited
NSE: LAURUSLABSINE947Q01028·HealthcareMidcap 150·www.lauruslabs.com ↗·Mcap ₹1.10L Cr·Listed 2016
₹2,007.00▼ ₹19.20  (−0.95%)
52W: ₹826 – ₹2,055 · Vol: 14.4L shares · Close 25 Sept
Set Alert
Overlay:
daily candles · adjustedloading full history…Charts by TradingView
Ask the chart: “Has this stock recovered from similar drawdowns before?”
Annual report FY26 — 18.20 MB · Shareholding pattern — Jun 2026 · All filings
AI equity note (bull/bear, numbers, sources) — coming soon
Management guidance consistency — coming soon

Latest filings

NSE announcements · newest first
No filings on record for LAURUSLABS yet.
P/E (TTM)
99.4×
EPS ₹20.20
P / Book
20.44×
BVPS ₹98
ROE
18.2%
FY26, avg equity
Net margin
13.1%
FY26
Revenue YoY
+29.1%
Q1 FY27
Net profit YoY
+123.9%
Q1 FY27
Debt / equity
0.45×
₹2,397 Cr debt
Div. yield
0.10%
₹2.00 in 12 months
From NSE filings (consolidated) and the last close.
Shareholding Pattern Jun 2026
Promoters
27.5%▼ 0.02
FIIs
28.0%▲ 2.18
DIIs
13.7%▼ 0.23
Retail
20.5%▼ 0.76
Others
10.3%▼ 1.17
Promoter pledge: none reported
Peer Comparison
Peer comparison is unavailable right now.
Forensic Flags
Forensic checks are unavailable right now.